Skip to content

Selegiline

Emsam (selegiline) is a small molecule pharmaceutical. Selegiline was first approved as Emsam on 2006-02-27. It is used to treat alzheimer disease, attention deficit disorder with hyperactivity, depressive disorder, parkinson disease, and schizophrenia in the USA. The pharmaceutical is active against amine oxidase [flavin-containing] B. In addition, it is known to target amine oxidase [flavin-containing] A.
Trade Name Emsam
Common Name Selegiline
Indication alzheimer disease, attention deficit disorder with hyperactivity, depressive disorder, parkinson disease, schizophrenia
Drug Class Mao inhibitors, type B
Selegiline
Get full access now